[PDF] Use Of Bovine Somatotropin Bst In The United States Its Potential Effects eBook

Use Of Bovine Somatotropin Bst In The United States Its Potential Effects Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Use Of Bovine Somatotropin Bst In The United States Its Potential Effects book. This book definitely worth reading, it is an incredibly well-written.

Review of Status and Potential Impact of Bovine Growth Hormone

Author : United States. Congress. House. Committee on Agriculture. Subcommittee on Livestock, Dairy, and Poultry
Publisher :
Page : 308 pages
File Size : 43,22 MB
Release : 1987
Category : Bovine somatotropin
ISBN :

GET BOOK

Bovine Somatotropin And Emerging Issues

Author : Milton C Hallberg
Publisher : CRC Press
Page : 289 pages
File Size : 19,12 MB
Release : 2019-04-09
Category : Science
ISBN : 0429709862

GET BOOK

Bovine somatotropin, or bST, a growth hormone genetically engineered to increase milk production in dairy cows, highlights the controversial issues of biotechnology and its widespread use. Focusing on the problems inherent in new and radically different technologies, this book develops a methodology for examining bST and other biotechnological deve

Bovine Somatotropin (bST)

Author : Jeannine M. Kenney
Publisher :
Page : 40 pages
File Size : 18,60 MB
Release : 1987
Category : Agricultural chemicals
ISBN :

GET BOOK

Issues and Dilemmas of Biotechnology

Author : Bernice Z. Schacter
Publisher : Bloomsbury Publishing USA
Page : 222 pages
File Size : 44,82 MB
Release : 1999-12-30
Category : Science
ISBN : 0313007438

GET BOOK

Recent advances in biotechnology in areas as diverse as agriculture, the environment, food, and healthcare have led to much debate and media attention. This unique reference resource for advanced high school students and teachers explores the science behind these new technologies and examines the stakeholders and their stakes in the various debates. The author presents views of scientists, doctors, insurance companies, and big businesses, among others, on such issues as genetic testing, patenting of human gene sequences, cloning, and genetically engineered food. Each chapter addresses a specific issue with the goals of helping readers understand all the different ways biotechnology is being explored and implemented in our lives today, as well as to critically perceive the arguments being made concerning these issues. Students will learn there is more to biotechnology than cloning sheep, that it is also used for such purposes as making cheese and beer. Each topic is presented as a Case Study describing of a range of technologies and a diversity of stakeholders that will allow users to draw their own conclusions. This introduction to the technologies and the debates surrounding them also encourages students to take advantage of the many available sources for further research, particularly on the Internet.

Science and Social Context

Author : Lisa N. Mills
Publisher : McGill-Queen's Press - MQUP
Page : 222 pages
File Size : 35,1 MB
Release : 2002-05-28
Category : Science
ISBN : 0773570276

GET BOOK

She examines the decision-making processes at Monsanto that led to their making the drug available and discusses corporate, academic, and regulatory decision-making in the context of a restructured global political economy for agriculture. Mills shows that there was consensus about the scientific evidence but interpretation of that evidence differed depending on the context from which it was viewed. Scientists who analysed it for regulatory bodies interpreted it differently than scientists in corporate or academic institutions, and scientists in Canada and Europe interpreted it differently than those in the United States. In the United States it was assumed that any problems arising from its use could be taken care of within the existing dairy system; in Canada and Europe these problems were regarded as legitimate animal welfare issues. While all regulatory bodies agreed that human health problems were unlikely, in Canada the Health Protection Branch questioned this, but ultimately rejected the drug on animal health grounds.